You Make the Call: Readers' Response

You Make the Call: Readers' Response

How readers responded to this month's You Make the Call question


Disclaimer: ASH does not recommend or endorse any specific tests, physicians, products, procedures, or opinions, and disclaims any representation, warranty, or guaranty as to the same. Reliance on any information provided in this article is solely at your own risk.

You Make the Call

Reader Responses: How would you treat this transplant-ineligible patient with Ph+ ALL?

Here’s how readers responded to a You Make the Call question about treatment options for a transplant-ineligible patient with Philadelphia chromosome-positive (Ph+) acute lymphocytic...
You Make the Call

Reader Responses: Is JAK2 positivity clinically significant in this 28-year-old patient with Budd-Chiari syndrome?

Here’s how readers responded to a You Make the Call question about the clinical significance of JAK2 positivity in a patient with Budd-Chiari syndrome. Disclaimer:...
You Make the Call

Reader Responses: How would you manage this patient with T-cell large granular lymphocytic leukemia?

Here’s how readers responded to a You Make the Call question about management of a patient with T-cell large granular lymphocytic leukemia. Disclaimer: ASH does...
You Make the Call

Reader Responses: How would you approach diathesis in a 65-year-old woman with newly diagnosed...

Here’s how readers responded to a You Make the Call question about a bleeding diathesis in a 65-year-old woman with newly diagnosed breast cancer. Disclaimer: ASH...
You Make the Call

Reader Responses: How would you treat this 38-year-old patient with sickle cell trait and end-stage...

Here’s how readers responded to a You Make the Call question about treatment for a patient with sickle cell trait and end-stage renal disease. Disclaimer:...
You Make the Call

Reader Responses: Should a mostly asymptomatic patient with amyloidosis receive systemic therapy?

Here’s how readers responded to a You Make the Call question about whether a mostly asymptomatic patient with amyloidosis should receive systemic therapy. Disclaimer: ASH...
You Make the Call

Reader Responses: How long should a young patient with COVID-19 and pulmonary embolism receive...

Here’s how readers responded to a You Make the Call question about anticoagulation for a young patient with COVID-19 and pulmonary embolism. Disclaimer: ASH does...
You Make the Call

Reader Responses: How would you treat a patient with aggressive systemic mastocytosis?

Here’s how readers responded to a You Make the Call question about treatment of bone manifestations and transplantation for systemic mastocytosis. Disclaimer: ASH does not...
You Make the Call

Reader Responses: How would you treat this patient with poor cytogenetics and low-grade B-cell...

Here’s how readers responded to a You Make the Call question about treatment of low-grade B-cell lymphoma with high-risk cytogenetics. Disclaimer: ASH does not recommend or...
You Make the Call

Reader Responses: Which direct oral anticoagulant would you choose for a submassive pulmonary embolism?

Here’s how readers responded to a You Make the Call question about choice of direct oral anticoagulant (DOAC) for a saddle pulmonary embolism. Disclaimer: ASH...
Advertisement

Current Issue

October 2021, Volume 7, Issue 12

This issue tells the long story of drug shortages, demystifies transfusion services, and more.

Block title